The Chinese biopharmaceutical sector has experienced a remarkable turnaround, entering 2026 with significant momentum. In 2025, the value of outbound licensing and drug development...
Asian stock markets displayed mixed performances as the trading day concluded, with the Philippines and South Korea showing gains while Hong Kong and Mainland...